Skip to main content

F Joseph McClernon, PhD

Professor in Psychiatry and Behavioral Sciences
Division: 
Behavioral Medicine & Neurosciences
Category: 
Office: 2608 Erwin Road, Suite 300, Durham, NC 27705
Campus Mail: DUMC 3527, Durham, NC 27710

Joe McClernon, Ph.D. is a Professor in the Department of Psychiatry and Behavioral Sciences, Founder/Director of the Center for Addiction Science and Technology (CfAST), and Director of Evaluation and Strategic Planning in the Duke Clinical and Translational Science Institute (CTSI). He earned a Ph.D. in clinical psychology in 2001 from Southern Illinois University-Carbondale and completed a postdoctoral fellowship at Duke in 2002. He served as Director of the Addiction Division in Psychiatry and Behavioral Sciences from 2012-2020. Joe’s research is focused on increasing our understanding of tobacco and other addictions, developing new and more effective interventions to treat substance abuse, and informing the FDA’s regulation of tobacco products. He makes use of behavioral pharmacology, neuroimaging, epidemiology and clinical trial approaches in his work. He has led groundbreaking research on: the influence of drug-associated environments on drug use, relapse, and treatment; tobacco use disparities among individuals with comorbid psychiatric (e.g. ADHD) and health (e.g. HIV) problems; the role of nicotine in smoking behavior; and the evaluation of potential FDA tobacco regulatory actions. He is an active mentor having trained six postdoctoral fellows, five of which are now faculty at academic medical centers across the country. He has been continuously NIH, FDA, and foundation funded since 2002. He has authored over 150 peer-reviewed publications, has one patent, has served as Chair of NIH grant review panels, and is recipient of numerous awards including the SRNT Jarvik-Russell New Investigator Award.

Education and Training

  • Ph.D., Southern Illinois University, 2001

Selected Grants

Publications

Oliver, Jason A., Maggie M. Sweitzer, Matthew M. Engelhard, Matthew B. Hallyburton, Kurt M. Ribisl, and Francis Joseph McClernon. “Identifying neural signatures of tobacco retail outlet exposure: Preliminary validation of a "community neuroscience" paradigm.” Addict Biol 26, no. 5 (September 2021): e13029. https://doi.org/10.1111/adb.13029.

Full Text

Sweitzer, Maggie M., Lauren R. Pacek, Rachel V. Kozink, Erin Locey, Scott H. Kollins, Eric C. Donny, and F Joseph McClernon. “Reactions to reduced nicotine content cigarettes in a sample of young adult, low-frequency smokers.” Psychopharmacology (Berl) 238, no. 9 (September 2021): 2429–38. https://doi.org/10.1007/s00213-021-05864-1.

Full Text

Pacek, Lauren R., Rachel V. Kozink, Christiane E. Carson, and F Joseph McClernon. “Appeal, subjective effects, and relative reinforcing effects of JUUL that vary in flavor and nicotine content.” Exp Clin Psychopharmacol 29, no. 3 (June 2021): 279–87. https://doi.org/10.1037/pha0000481.

Full Text

Pacek, Lauren R., Alicia D. Holloway, Karen L. Cropsey, Christina S. Meade, Maggie M. Sweitzer, James M. Davis, and F. Joseph McClernon. “Experiences With Smoking Cessation Attempts and Prior Use of Cessation Aids in Smokers With HIV: Findings From a Focus Group Study Conducted in Durham, North Carolina.” Aids Educ Prev 33, no. 2 (April 2021): 158–68. https://doi.org/10.1521/aeap.2021.33.2.158.

Full Text

Cassidy, Rachel N., Jennifer W. Tidey, Qing Cao, Suzanne M. Colby, Francis J. McClernon, Tracy T. Smith, Sarah Dermody, et al. “Responses to Gradual and Immediate Reduction of Nicotine in Cigarettes in Young vs. Older Adult Smokers.” Nicotine Tob Res, March 23, 2021. https://doi.org/10.1093/ntr/ntab049.

Full Text

Pacek, Lauren R., Alicia D. Holloway, Karen L. Cropsey, Christina S. Meade, Maggie M. Sweitzer, James M. Davis, and F Joseph McClernon. “Cigarette Smoking and Cessation-Related Interactions With Health Care Providers in the Context of Living With HIV: Focus Group Study Findings.” J Assoc Nurses Aids Care 32, no. 2 (March 2021): e14–19. https://doi.org/10.1097/JNC.0000000000000185.

Full Text

Denlinger-Apte, Rachel L., Joseph S. Koopmeiners, Jennifer W. Tidey, Xianghua Luo, Tracy T. Smith, Lauren R. Pacek, F. Joseph McClernon, et al. “Support for a nicotine reduction policy among participants enrolled in a 20-week trial of very low nicotine content cigarettes.” Addictive Behaviors 114 (March 2021): 106727. https://doi.org/10.1016/j.addbeh.2020.106727.

Full Text

Vilardaga, Roger, Javier Rizo, Paige E. Palenski, Paolo Mannelli, Jason A. Oliver, and Francis J. McClernon. “Erratum to: Pilot Randomized Controlled Trial of a Novel Smoking Cessation App Designed for Individuals With Co-Occurring Tobacco Dependence and Serious Mental Illness.” Nicotine Tob Res 23, no. 2 (January 22, 2021): 411. https://doi.org/10.1093/ntr/ntaa125.

Full Text

Sweitzer, Maggie, Kayla Hernandez, Jacqueline Soja, Joseph McClernon, and Erika Forbes. “Neural Correlates of Social Reward Processing Differ Between Young Adult Smokers and Non-Smokers.” In Neuropsychopharmacology, 45:145–145, 2020.

Scholars@Duke

Vilardaga, Roger, Tykira Fisher, Paige E. Palenski, Viggy Kumaresan, Paolo Mannelli, Maggie M. Sweitzer, Francis Joseph McClernon, Matthew M. Engelhard, Patricia L. Sabo, and Kathleen A. Garrison. “Review of Popularity and Quality Standards of Opioid-Related Smartphone Apps.” Curr Addict Rep 7, no. 4 (December 2020): 486–96. https://doi.org/10.1007/s40429-020-00344-6.

Full Text

Pages